CRNX
Crinetics Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $3.96B | Price | $42.77 |
| Volume | 486.69K | Change | -1.69% |
| P/E Ratio | -13.3 | Open | $43.30 |
| Revenue | $1.0M | Prev Close | $43.50 |
| Net Income | $-298.4M | 52W Range | $24.10 - $62.53 |
| Div Yield | N/A | Target | $79.19 |
| Overall | 60 | Value | 60 |
| Quality | 55 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyCrinetics Pharmaceuticals Inc. (CRNX) is a leading Healthcare company in the Biotechnology industry, currently trading at $42.77 with a market capitalization of $3.96 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows CRNX with a volume of 487K shares. The stock opened down 0.46% from yesterday's close of $43.50. Current analyst estimates project earnings of $-4.85 per share for this year, with next year targeting $-5.18.
CRNX demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CRNX include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 85.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:27 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRNX | $42.77 | -1.7% | 486.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crinetics Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW